Tiziana Life Sciences (TLSA) Receivables - Net (2017 - 2022)
Tiziana Life Sciences (TLSA) posted quarterly Receivables - Net of $300000.0 for Q4 2022, down 76.94% year-over-year from $1.3 million in Q4 2021, and down 76.94% quarter-over-quarter from $1.3 million in Q4 2021.
Tiziana Life Sciences (TLSA) Receivables - Net (2017 - 2022) Analysis & Trends
Tiziana Life Sciences' Receivables - Net history runs 6 years deep, the most recent figure standing at $300000.0 for Q4 2022.
- In Q4 2022, Receivables - Net fell 76.94% year-over-year to $300000.0; the TTM figure through Dec 2022 stood at $300000.0 (down 76.94% YoY), while the FY2022 annual figure was $300000.0, down 76.94% from the prior year.
- Receivables - Net for Q4 2022 stood at $300000.0, down from $1.3 million in the prior quarter.
- The five-year high for Receivables - Net was $1.3 million in Q4 2021, with the low at $165000.0 in Q4 2019.
- The 5-year median for Receivables - Net is $785000.0 (2020), against an average of $724000.0.
- The sharpest annual moves came in 2019 and 2020: Receivables - Net slumped 84.57% in 2019, then soared 375.76% in 2020.
- Tiziana Life Sciences' Receivables - Net stood at $1.1 million in 2018, then plunged by 84.57% to $165000.0 in 2019, then jumped by 375.76% to $785000.0 in 2020, then soared by 65.73% to $1.3 million in 2021, then slumped by 76.94% to $300000.0 in 2022.
- Business Quant data shows TLSA's Receivables - Net at $300000.0 in Q4 2022, $1.3 million in Q4 2021, and $785000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 300,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 1.30 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Dec 31, 2020 | 785,000.00 |
| Dec 31, 2020 | 785,000.00 |
| Dec 31, 2019 | 165,000.00 |
| Dec 31, 2019 | 165,000.00 |
| Dec 31, 2018 | 1.07 Mn |
| Dec 31, 2018 | 1.07 Mn |
| Dec 31, 2017 | 2.38 Mn |
| Dec 31, 2017 | 2.38 Mn |